Characterization of Metabolic Biomarkers in Varying Subjects
NCT ID: NCT01199692
Last Updated: 2023-03-14
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
COMPLETED
250 participants
OBSERVATIONAL
2010-08-31
2022-12-31
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Metabolically Healthy Obesity: Correlations Between BMI and Metabolic Syndrome Biomarkers
NCT03195712
Physical and Behavioral Traits of Overweight and Obese Adults
NCT00428987
Dietary, Physiological, Genetic, and Behavioral Predictors of Health in a Young, Ethnically-Mixed Population
NCT00945633
Biomarkers of Metabolic Obesity.
NCT05604196
Biobehavioral Determinants of Obesity in Black Women
NCT00005386
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
* Medical record review and follow-up
* Fasting blood sample (volume limitations stipulated within)
* Pre-meal, during meal, and post-meal blood sample (volume limits within)
* Short-term and/or long-term dietary intervention (MD approved)
* Short-term and/or long-term exercise intervention (MD approved)
* Blood glucose log
* Food and exercise diaries
* Pre- and post-medication blood sampling (neutraceutical or Rx products)
* 24-hour urine sampling
* Spot urine sampling
* Stool microbiologic sampling
* Intestinal microbiologic sampling (gastric bypass subjects only)
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
CASE_CONTROL
PROSPECTIVE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
Age
No interventions assigned to this group
Gender
No interventions assigned to this group
Ethnicity
No interventions assigned to this group
Body Mass Distribution
No interventions assigned to this group
Dietary Habits
No interventions assigned to this group
Exercise Habits
No interventions assigned to this group
Medication Requirements
No interventions assigned to this group
Disease State Burden
No interventions assigned to this group
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* Weight =\>110 pounds
Exclusion Criteria
* Weight \<110 pounds
* Pregnant
* Poor venous access or poor likelihood to adhere with study procedures
18 Years
100 Years
ALL
Yes
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
CPL Associates
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Scott Monte
Program Director
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Scott Monte, PharmD
Role: PRINCIPAL_INVESTIGATOR
CPL Associates, LLC
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Synergy Bariatrics, A Department of ECMC
Williamsville, New York, United States
Countries
Review the countries where the study has at least one active or historical site.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
CPL201006A
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.